Literature DB >> 16476901

Ocular adverse effects associated with cyclooxygenase-2 inhibitors.

Frederick W Fraunfelder1, Jonathan Solomon, Thomas J Mehelas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476901     DOI: 10.1001/archopht.124.2.277

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  11 in total

Review 1.  Ocular adverse effects associated with systemic medications : recognition and management.

Authors:  Ricardo M Santaella; Frederick W Fraunfelder
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Determination of nonsteroidal anti-inflammatory drugs in human tear and plasma samples using ultra-fast liquid chromatography-tandem mass spectrometry.

Authors:  Makiko Hirosawa; Takehiko Sambe; Naoki Uchida; Xiao-Pen Lee; Keizo Sato; Shinichi Kobayashi
Journal:  Jpn J Ophthalmol       Date:  2015-06-19       Impact factor: 2.447

Review 3.  Ocular toxicity from systemically administered xenobiotics.

Authors:  Mitan R Gokulgandhi; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-07-18       Impact factor: 4.481

Review 4.  Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.

Authors:  V Peponis; V C Kyttaris; S E Chalkiadakis; S Bonovas; N M Sitaras
Journal:  Lupus       Date:  2010-02-09       Impact factor: 2.911

5.  Effects of celecoxib on ionic currents and spontaneous firing in rat retinal neurons.

Authors:  R V Frolov; M M Slaughter; S Singh
Journal:  Neuroscience       Date:  2008-05-09       Impact factor: 3.590

6.  Optic neuropathy secondary to dasatinib in the treatment of a chronic myeloid leukemia case.

Authors:  Katia Sotelo Monge; Alberto Gálvez-Ruiz; Alberto Alvárez-Carrón; César Quijada; Anna Matheu
Journal:  Saudi J Ophthalmol       Date:  2015-01-06

7.  Impact of Flow Rate, Collection Devices, and Extraction Methods on Tear Concentrations Following Oral Administration of Doxycycline in Dogs and Cats.

Authors:  Lionel Sebbag; Lucas Showman; Emily M McDowell; Ann Perera; Jonathan P Mochel
Journal:  J Ocul Pharmacol Ther       Date:  2018-04-30       Impact factor: 2.671

8.  Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides.

Authors:  Scott D Smid
Journal:  Clin Ophthalmol       Date:  2009-12-29

Review 9.  Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs.

Authors:  Lise Aagaard; Ebba Holme Hansen
Journal:  BMC Clin Pharmacol       Date:  2009-03-03

Review 10.  Ocular side effects of antirheumatic medications: a qualitative review.

Authors:  Clara M Castillejo Becerra; Yue Ding; Beatrice Kenol; Andrew Hendershot; Alexa Simon Meara
Journal:  BMJ Open Ophthalmol       Date:  2020-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.